A team of scientists, including those from Janssen and the Lung Cancer Initiative at Johnson & Johnson, found that biomarkers related to the immune system may be able to aid doctors in identifying high-risk lung cancer patients—and treating them—at the earliest stage of the disease.
We sat down with the winner of the 2018 Dr. Paul Janssen Award for Biomedical Research to learn how his tireless cancer research efforts have helped revolutionize the way we treat the disease—and save lives.
Johnson & Johnson and Chinese company Legend Biotech have teamed up to work on a new form of treatment for the incurable blood cancer. We interview Dr. Sen Zhuang about the unique collaboration—and the promise it holds.
For National Cancer Prevention Month, we talked to a pair of top experts about common falsehoods about the disease—and what the latest science says about cancer prevention truths.
“Finding a cure is personal": 3 scientists share what it’s like to work on a disease that’s touched their lives
Bringing your passion to work has taken on new meaning for these inspiring Johnson & Johnson researchers.
Imagine if your doctor could detect cancer before it began growing in your body, then give you medicine to prevent it from taking hold. This researcher explains how she and other scientists are working to someday make this cutting-edge concept a reality.